Zhaozhong Zhu रीट्वीट किया
Very proud to launch our official website of the Canadian Bronchiectasis and NTM registry! Excited to continue its growth in the years to come! 🫁 @CTS_SCT @UCalgary: bxconnect.org
English
Zhaozhong Zhu
430 posts
Zhaozhong Zhu
@hellofuture100
Assistant Professor @MassGenBrigham, asthma, genetics, microbiome, multi-omics, dad, husband, swimmer
Boston, MA शामिल हुए Mayıs 2017
89 फ़ॉलोइंग151 फ़ॉलोवर्स
Happy to share our latest work published in the ERJ Open Research @ERSpublications! We uncovered metabolomic signatures linked to asthma risk and clinical heterogeneity.
Great team effort led by my stellar fellow Heidi! @HMakrinioti
publications.ersnet.org/content/erjor/…
English
Zhaozhong Zhu रीट्वीट किया
Inhaled immunoglobulin as a novel treatment for bronchiectasis: results from a phase 1 trial
Inhaled immunoglobulin G was associated with low rates of adverse events and reduced airway bacterial burden. Encouraging results! Online now at @ATSBlueEditor
academic.oup.com/ajrccm/advance…
English
Zhaozhong Zhu रीट्वीट किया
ERS publications@ERSpublications
European Respiratory Journal: In this trial, conducted in 674 adults with dyspnoea as chief complaint for emergency department visits, a point-of-care ultrasound-driven diagnostic pathway did not shorten the length of stay within 24 h or overall bit.ly/4oJ1i1x
English
Zhaozhong Zhu रीट्वीट किया
Zhaozhong Zhu रीट्वीट किया
Last week to submit – deadline 31 March!
The European Respiratory Journal seeks high-quality papers on respiratory infections for a special series due to be published later this year. Submit before the deadline: mc.manuscriptcentral.com/erj
English
Zhaozhong Zhu रीट्वीट किया
New paper from EMBARC
Dysregulation of immunoglobulins in the airway in bronchiectasis. Further evidence that antibody mediated immunity is impaired in BE and supporting an upcoming trial of antibody treatment for this disease @ERSpublications
publications.ersnet.org/content/erjor/…
English
Zhaozhong Zhu रीट्वीट किया
Check our new interactive learning module on bronchiectasis - talking about the new ERS guidelines and much more with Sanjay Chotirmall and Natalie Lorent ❤️
ERS@EuroRespSoc
New Interactive Education: Unmasking bronchiectasis – From guidelines to the bedside: expert case reflections Join the experts as they discuss the critical need for high-quality, case-based learning to help clinicians improve practice in bronchiectasis: channel.ersnet.org/media-121211-u…
English
Zhaozhong Zhu रीट्वीट किया
Our latest paper just out in @LancetRespirMed
10 unanswered questions about DPP1 inhibition in bronchiectasis
We outline key future clinical and research questions after the approval of the first new therapy for people with bronchiectasis.
Congratulations Jiahui, Chloe and @MereteLong
English
Zhaozhong Zhu रीट्वीट किया
Bit ridiculous to call ‘remission’ when on biologics but the point is an important one, that disease control even on biologics is dynamic in #asthma
ERS publications@ERSpublications
Eur Respir J: In severe asthma, patients experience long-term efficacy on anti-IL5/Rα biologics with notable improvements in disease control. However, remission is a dynamic state, with only 7.7% of patients experiencing sustained remission over 5 years. bit.ly/4qKpFNA
English
Zhaozhong Zhu रीट्वीट किया
UCB therapeutics announces they will trial anti-IL17/IL-13 multispecific antibody therapy in bronchiectasis in 2026
The pipeline of new therapies coming into the bronchiectasis and COPD field is exciting to see and will ultimately be great for patients.
ucb.com/newsroom/press…
English
Zhaozhong Zhu रीट्वीट किया
The first approved treatment for bronchiectasis ever in the UK. MHRA approved brensocatib for bronchiectasis patients aged 12 and over
gov.uk/government/new…
English
Zhaozhong Zhu रीट्वीट किया
What are the global challenges in #asthma and #COPD. Here I discuss these issues with Prof. Halpin in a short podcast.
ERS publications@ERSpublications
The ERJ presents the latest in its series of podcasts. @donsin4 interviews David Halpin about his Viewpoint editorial on a shared vision from @GOLD_COPD and @ginasthma of how to address the global challenges of COPD and asthma soundcloud.com/erjpodcast/erj…
English
Zhaozhong Zhu रीट्वीट किया
Characterisation of the eosinophilic endotype of bronchiectasis
We use a novel method of quantifying eosinophil granule proteins in sputum: Eosinophilic inflammation is present in bronchiectasis but poorly associated with blood eosinophils
@EMBARCnetwork
thorax.bmj.com/content/early/…
English
Zhaozhong Zhu रीट्वीट किया
Get your abstracts in for the best respiratory meeting in the world ❤️
ERS@EuroRespSoc
The submission of abstracts (first round) and clinical cases ends tomorrow (12 February) for the #ERSCongress 2026 (5–9 September, 2026 in Barcelona, Spain and online)! Don't miss this opportunity – submit online: ersnet.org/congress-and-e…
English
Zhaozhong Zhu रीट्वीट किया
Zhaozhong Zhu रीट्वीट किया
The ERJ editors review 2025 and give a taste of what to look forward to in 2026 bit.ly/4sEgYWb
English
Zhaozhong Zhu रीट्वीट किया
Announcing a new commission aiming to transform global management and research into bronchiectasis
Thank you @LancetRespirMed
thelancet.com/journals/lanre…
English
Zhaozhong Zhu रीट्वीट किया
Zhaozhong Zhu रीट्वीट किया
Come and join us for a rapid update on this months controversies and conversations in Respiratory Medicine
Live on monday!
ERS@EuroRespSoc
📺 Respiratory News Live launches in just 2️⃣ days – live on the ERS Respiratory Channel! This first-of-its-kind online news resource will provide you with the latest, most significant findings in respiratory medicine & science. Register: channel.ersnet.org/media-115110-e… @ProfJDChalmers
English